Order Article Reprints

Buhlak S, Abad N, Akachar J, Saffour S, Kesgun Y, Dik S, Yasin B, Bati-Ayaz G, Hanashalshahaby E, Türkez H, et al. Design, Synthesis, and Computational Evaluation of 3,4-Dihydroquinolin-2(1H)-One Analogues as Potential VEGFR2 Inhibitors in Glioblastoma Multiforme. Pharmaceuticals. 2025; 18(2):233. https://doi.org/10.3390/ph18020233

Buhlak, Shafeek, Nadeem Abad, Jihane Akachar, Sana Saffour, Yunus Kesgun, Sevval Dik, Betul Yasin, Gizem Bati-Ayaz, Essam Hanashalshahaby, Hasan Türkez, and et al. 2025. "Design, Synthesis, and Computational Evaluation of 3,4-Dihydroquinolin-2(1H)-One Analogues as Potential VEGFR2 Inhibitors in Glioblastoma Multiforme" Pharmaceuticals 18, no. 2: 233. https://doi.org/10.3390/ph18020233

Buhlak, S., Abad, N., Akachar, J., Saffour, S., Kesgun, Y., Dik, S., Yasin, B., Bati-Ayaz, G., Hanashalshahaby, E., Türkez, H., & Mardinoglu, A. (2025). Design, Synthesis, and Computational Evaluation of 3,4-Dihydroquinolin-2(1H)-One Analogues as Potential VEGFR2 Inhibitors in Glioblastoma Multiforme. Pharmaceuticals, 18(2), 233. https://doi.org/10.3390/ph18020233